Korsana Biosciences, Inc.
KRSANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for KRSA. That does not mean none is planned.
Get an email about KRSA's next catalysts
Track Korsana Biosciences (KRSA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
KRSA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.78 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Frequently asked questions
What is in Korsana Biosciences, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Korsana Biosciences, Inc.'s (KRSA) pipeline across Phase 2. Its lead program is IW-1701 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Korsana Biosciences, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Korsana Biosciences, Inc. (KRSA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track KRSA biotech catalysts?→
Add KRSA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Korsana Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.